细胞分离市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

细胞分离市场按产品(消耗品(试剂和试剂盒、珠子和一次性用品)、仪器(离心机、流式细胞仪、过滤系统、磁激活细胞分离系统)、类型、应用和地理位置进行细分。

市场快照

 Cell Isolation Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 17.2 %
Cell Isolation Market Growth

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,所研究的细胞分离/细胞分离市场预计将以 17.2% 的复合年增长率增长。细胞分离/细胞分离技术通常用于疾病诊断、细胞研究和细胞治疗。人口老龄化导致慢性病发病率和患病率增加、对生物制药的需求不断增长、细胞分离技术进步以及干细胞研究增加等因素正在推动细胞分离/细胞分离市场。 

根据世界卫生组织 (WHO) 的数据,癌症是全球第二大死因,2018 年估计有 960 万人死亡。在全球范围内,大约六分之一的死亡是由癌症引起的。大约 70% 的癌症死亡发生在低收入和中等收入国家。因此,随着慢性病的日益流行,细胞分离技术的进步和创新是细胞分离市场的关键驱动因素。

报告范围

根据报告的范围,细胞分离或细胞分离是一种用于将细胞从异质细胞群中分选到特定群体中而不受污染的技术,该技术有助于基于细胞的疗法提高治疗质量和临床结果. 

By Product
Consumables
Reagents & kits
Beads
Disposables
Instruments
Centrifuges
Flow cytometers
Filtration systems
Magnetic-activated cell separator systems
By Type
Human
Animal
By Application
Research Laboratories and Institutes
Biotechnology and Biopharmaceutical Companies
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

人体细胞细分市场有望在细胞分离市场占有重要份额

人类细胞疗法是一种使用细胞分离/分离技术将活细胞注射到患者体内以治疗多种疾病的疗法。例如,将 T 细胞注射到患者体内以治疗癌症,因为它们能够在免疫疗法治疗期间对抗癌细胞。

根据世界卫生组织 (WHO) 的数据,癌症是全球第二大死因,2018 年估计有 960 万人死亡。在全球范围内,大约六分之一的死亡是由癌症引起的。大约 70% 的癌症死亡发生在低收入和中等收入国家。 

因此,慢性病的日益流行以及细胞分离技术的进步和创新是人类细胞领域的关键驱动因素。

Cell Isolation Market Size

北美预计将主导市场,并预计在预测期内做同样的事情

由于完善的生命科学研究基础设施以及专注于开发新疗法的公司的高度组织化监管结构,预计北美将在全球细胞分离市场占据主导地位。 

根据美国国家癌症研究所的数据,2018 年,美国估计新诊断出 1,735,350 例癌症病例,将有 609,640 人死于该病。此外,私人和公共参与者增加研发支出也将促进该市场的增长。

Cell Isolation Market Segment

竞争格局

细胞分离市场是分散竞争的,由多个市场参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。一些参与者正在采取包括收购和合作在内的多种策略来维持市场竞争。目前主导市场的一些公司包括 Becton Dickinson and Company、GE Healthcare、Merck KgaA、Thermo Fisher Scientific、Bio-Rad Laboratories Inc、Terumo BCT、PluriSelect Life Science UG & Co. KG、MiltenyiBiotec、Beckman Coulter, Inc和干细胞技术公司。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic Diseases

      2. 4.2.2 Technological Advancement and Innovation in Cell Isolation

    3. 4.3 Market Restraints

      1. 4.3.1 Strict Regulations and Compliances for Cell Separation

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Consumables

        1. 5.1.1.1 Reagents & kits

        2. 5.1.1.2 Beads

        3. 5.1.1.3 Disposables

      2. 5.1.2 Instruments

        1. 5.1.2.1 Centrifuges

        2. 5.1.2.2 Flow cytometers

        3. 5.1.2.3 Filtration systems

        4. 5.1.2.4 Magnetic-activated cell separator systems

    2. 5.2 By Type

      1. 5.2.1 Human

      2. 5.2.2 Animal

    3. 5.3 By Application

      1. 5.3.1 Research Laboratories and Institutes

      2. 5.3.2 Biotechnology and Biopharmaceutical Companies

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Becton Dickinson and Company

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Merck KgaA

      4. 6.1.4 Thermo Fisher Scientific

      5. 6.1.5 Bio-Rad Laboratories Inc

      6. 6.1.6 Terumo BCT

      7. 6.1.7 PluriSelect Life Science UG & Co. KG

      8. 6.1.8 MiltenyiBiotec

      9. 6.1.9 Beckman Coulter, Inc

      10. 6.1.10 STEMCELL Technologies Inc

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cell Isolation Market market is studied from 2018 - 2026.

The Cell Isolation Market is growing at a CAGR of 17.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Becton Dickinson and Company, GE Healthcare, Merck KgaA, Thermo Fisher Scientific, Bio-Rad Laboratories Inc are the major companies operating in Cell Isolation Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!